News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Jeremy M. Shefner, MD, PhD

Articles by Jeremy M. Shefner, MD, PhD

Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion

ByBenjamin Rix Brooks, MD,James A. Jorgenson, MS, RPh, FASHP,Barbara J. Newhouse, MS, BSW,Jeremy M. Shefner, MD, PhD,Wendy Agnese, PharmD

April 25th 2018

Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion Appendix

ByBenjamin Rix Brooks, MD,James A. Jorgenson, MS, RPh, FASHP,Barbara J. Newhouse, MS, BSW,Jeremy M. Shefner, MD, PhD,Wendy Agnese, PharmD

April 25th 2018

Latest Updated Articles

Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion
Published: April 25th 2018 | Updated:
Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion Appendix
Published: April 25th 2018 | Updated:

Trending on AJMC

Government Shutdown Concluded but ACA Subsidies in Limbo

FDA Approves Ziftomenib for R/R NPM1-Mutated AML

Gas-Permeable Contact Lenses Provide Superior VA in Children After Surgery

How MS Treatment Strategies Are Evolving: Rebecca Spain, MD

Can a Coffee a Day Keep AFib Away?

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.